ALT - Altimmune - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALT is currently covered by 4 analysts with an average price target of $17.02. This is a potential upside of $12.97 (320.25%) from yesterday's end of day stock price of $4.05.

Altimmune's activity chart (see below) currently has 90 price targets and 90 ratings on display. The stock rating distribution of ALT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 11.53% with an average time for these price targets to be met of 31.91 days.

Highest price target for ALT is $18, Lowest price target is $12, average price target is $15.

Most recent stock forecast was given by MAYANK MAMTANI from B. RILEY on 13-Aug-2025. First documented stock forecast 01-Jun-2020.

Currently out of the existing stock ratings of ALT, 14 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$18

$13.95 (344.44%)

$20

2 months 20 days ago
(13-Aug-2025)

4/17 (23.53%)

$14.26 (381.28%)

214

Buy

$12

$7.95 (196.30%)

$12

2 months 20 days ago
(13-Aug-2025)

0/19 (0%)

$8.26 (220.86%)

Buy

$26

2 months 20 days ago
(13-Aug-2025)

0/1 (0%)

$16.51 (173.97%)

Buy

$15

$10.95 (270.37%)

3 months 23 days ago
(10-Jul-2025)

0/15 (0%)

$10.6 (240.91%)

Buy

$25

$20.95 (517.28%)

$25

1 years 4 months 12 days ago
(21-Jun-2024)

3/15 (20%)

$18.59 (290.02%)

42

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALT (Altimmune) average time for price targets to be met?

On average it took 31.91 days on average for the stock forecasts to be realized with a an average price target met ratio 11.53

Which analyst has the current highest performing score on ALT (Altimmune) with a proven track record?

MAYANK MAMTANI

Which analyst has the most public recommendations on ALT (Altimmune)?

Mayank Mamtani works at B. RILEY and has 2 price targets and 1 ratings on ALT

Which analyst is the currently most bullish on ALT (Altimmune)?

Roger Song with highest potential upside - $30.95

Which analyst is the currently most reserved on ALT (Altimmune)?

Kelechi Chikere with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?